Literature DB >> 10739934

Crystallization and preliminary X-ray crystallographic analysis of human nucleoside diphosphate kinase A.

K Min1, S Y Kim, H K Song, C Chang, S J Cho, J Moon, J K Yang, J Y Lee, K J Lee, S W Suh.   

Abstract

Human nucleoside diphosphate kinase A catalyzes phosphoryl transfer and acts as a suppressor of metastasis. It has been crystallized using 2-methyl-2,4-pentanediol as a precipitant at 288 K. The crystal is monoclinic, belonging to the space group P2(1), with unit-cell parameters a = 74.21, b = 78.11, c = 82.29 A, beta = 101. 33 degrees. The asymmetric unit contains a homohexamer, with a corresponding crystal volume per protein mass (V(m)) of 2.27 A(3) Da(-1) and a solvent content of 46%. Native X-ray data to 2.15 A resolution have been collected using synchrotron X-rays.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739934

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  4 in total

Review 1.  Three-dimensional structure of nucleoside diphosphate kinase.

Authors:  J Janin; C Dumas; S Moréra; Y Xu; P Meyer; M Chiadmi; J Cherfils
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 2.  The human Nm23/nucleoside diphosphate kinases.

Authors:  M L Lacombe; L Milon; A Munier; J G Mehus; D O Lambeth
Journal:  J Bioenerg Biomembr       Date:  2000-06       Impact factor: 2.945

Review 3.  Activation of Nm23-H1 to suppress breast cancer metastasis via redox regulation.

Authors:  Bokyung Kim; Kong-Joo Lee
Journal:  Exp Mol Med       Date:  2021-03-22       Impact factor: 8.718

4.  Transglutaminase 2 and nucleoside diphosphate kinase activity are correlated in epithelial membranes and are abnormal in cystic fibrosis.

Authors:  Kate J Treharne; O Giles Best; Anil Mehta
Journal:  FEBS Lett       Date:  2009-07-18       Impact factor: 4.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.